NIH-funded research U01 cooperative agreement

Sex differences in delayed gut fibrosis after radiation exposure

Official title: Sex differences in delayed development of gastrointestinal fibrosis after acute radiation exposure

Funded at Duke University · NIH-11332821 · Data updated 2026-11-12

This grant looks at why the small intestine and colon develop scar tissue differently in men and women after high-dose radiation exposure, with the aim of finding ways to prevent or lessen this delayed injury.

More Fibrosis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startJune 3, 2024
Project endMay 31, 2027
Funding year2026
Award (this year)$550,427
NIH project number5U01AI183940-03
Project IDNIH-11332821 on NIH RePORTER

Who could benefit from this research

Could help

People with exposure to acute radiation who might benefit from future therapies targeting gut fibrosis.

Less likely to help

Patients not exposed to radiation or those not affected by gut fibrosis may not directly benefit.

What this research studies

If radiation causes damage to the gut, scar tissue can form later and harm function. The project uses mouse models to study how biological sex influences the long-term fibrosis after radiation and whether Type I interferon signaling plays a protective or harmful role. By comparing male and female mice with a specific genetic background, researchers hope to reveal mechanisms that could lead to sex-specific therapies for radiation-induced gut injury. The findings could guide future human studies and help prepare targeted countermeasures for people exposed to radiation accidents or nuclear events.

Why it matters

Potential benefit: Could lead to sex-specific strategies to prevent or reduce delayed gut fibrosis after radiation exposure.

How similar studies have gone: Previous work suggests sex differences matter in radiation response, but this study probes mechanisms in the gut and Type I interferon signaling.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Roper, Jatin — Duke University
  • Study coordinator: Roper, Jatin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.